Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Toronto Stock Exchange  >  Transition Therapeutics Inc    TTH   CA8937162094

 SummaryChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Toronto Stock Exchange
05/20/2016 05/24/2016 05/25/2016 05/26/2016 05/27/2016 Date
1.04 1.05 1.01 1.05 1.04 Last
30100 9900 4300 21100 7100 Volume
+4.00% +0.96% -3.81% +3.96% -0.95% Change
Financials ( CAD)
More Financials
Company
Transition Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapeutics for disease indications with large markets.It operates through research and development of therapeutic agents segment.The company's products include ELND005 for the treatment of alzheimer's... 
Sector
Pharmaceuticals
Calendar
09/13Earnings Release
More about the company
Latest news on TRANSITION THERAPEUTICS IN
05/11 TRANSITION THERAPEUTICS : Announces Third Quarter Fiscal 2016 Financial Results
05/09 TRANSITION THERAPEUTICS TO HOLD CONF : 30 p.m. est
04/18 TRANSITION THERAPEUTICS : Provides Update on Type 2 Diabetes Drug Candidate TT40..
03/17 TRANSITION THERAPEUTICS : Receives Notification From NASDAQ
03/01 TRANSITION THERAPEUTICS : to Present at the 36th Annual Cowen Healthcare Confere..
02/09 TRANSITION THERAPEUTICS : Announces Second Quarter Fiscal 2016 Financial Results
02/05 TRANSITION THERAPEUTICS : to Hold Conference Call on Second Quarter Fiscal 2016 ..
02/01 TRANSITION THERAPEUTICS : Announces Top Line Phase 2 Clinical Study Results of D..
01/06 TRANSITION THERAPEUTICS : Announces Annual General Meeting Voting Results
2015 TRANSITION THERAPEUTICS : to Host Investor Day November 23 in New York
More news
Sector news : Biopharmaceuticals
02:55aDJBAYER : Invites Environmental Groups to Discuss Monsanto
05/29 JOHNSON & JOHNSON : Telling the stories of a son fallen in combat, and also vete..
05/28 SUN PHARMACEUTICAL : Pharma Q4 profit seen up 113%, Gleevec may drive US sales
05/28 TAKEDA PHARMACEUTICAL : Receives Positive CHMP Opinion for ADCETRIS (brentuximab..
05/28DJCovestro Eyes Acquisitions, Says Finance Chief - Report
More sector news : Biopharmaceuticals
News from SeekingAlpha
05/11 Transition Therapeutics' (TTHI) CEO Chip Brewer on Q3 2016 Results - Earnings..
05/11 Transition Therapeutics reports FQ3 results
04/26 First patient dosed in Transition's mid-stage study of TT701 in androgen defi..
04/18 Midday Gainers/ Losers
04/18 Lilly bags development of Transition Therapeutics' diabetes candidate TT401
Advertisement
Chart TRANSITION THERAPEUTICS IN
Duration : Period :
Transition Therapeutics In Technical Analysis Chart | TTH | CA8937162094 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions